Ketamine-related expression of glutamatergic postsynaptic density genes: Possible implications in psychosis

Neuroscience Letters

Volumn 416, Issue 1, 2007, Pages 1-5

  Iasevoli, Felice ^a   Polese, Daniela ^a   Ambesi Impiombato, Alberto ^a   Muscettola, Giovanni ^a   de Bartolomeis, Andrea ^a  

^a Section of Psychiatry   (Italy)

Author keywords

Dopamine; Glutamate; Homer1; Ketamine; PSD; Schizophrenia

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; GENE; GENE EXPRESSION; HISTOCHEMISTRY; HOMER1A GENE; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOSIS; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TEGMENTUM;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CEREBRAL CORTEX; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GLUTAMIC ACID; KETAMINE; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPSES;

EID: 33947252356     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.041     Document Type: Article

References (38)

1. Adams B., and Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18 (1998) 5545-5554
2. Ambesi-Impiombato A., D'Urso G., Muscettola G., and de Bartolomeis A. Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. Brain Res. Brain Res. Protoc. 11 (2003) 189-196
3. Anand A., Charney D.S., Oren D.A., Berman R.M., Hu X.S., Cappiello A., and Krystal J.H. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-d-aspartate receptor antagonists. Arch. Gen. Psychiatry 57 (2000) 270-276
4. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., and Worley P.F. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386 (1997) 284-288
5. Breier A., Adler C.M., Weisenfeld N., Su T.P., Elman I., Picken L., Malhotra A.K., and Pickar D. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29 (1998) 142-147
6. Cochran S.M., Fujimura M., Morris B.J., and Pratt J.A. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 46 (2002) 206-214
7. David H.N., Ansseau M., and Abraini J.H. Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res. Brain Res. Rev. 50 (2005) 336-360
8. de Bartolomeis A., Aloj L., Ambesi-Impiombato A., Bravi D., Caraco C., Muscettola G., and Barone P. Acute administration of antipsychotics modulates Homer striatal gene expression differentially. Brain Res. Mol. Brain Res. 98 (2002) 124-129
9. de Bartolomeis A., Fiore G., and Iasevoli F. Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. Curr. Pharm. Des. 11 (2005) 3561-3594
10. de Bartolomeis A., and Iasevoli F. The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol. Bull. 37 (2003) 51-83
11. French E.D., Ceci A., and Non-competitive. N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett. 119 (1990) 159-162
12. Kalivas P.W., Szumlinski K.K., and Worley P. Homer2 gene deletion in mice produces a phenotype similar to chronic cocaine treated rats. Neurotox. Res. 6 (2004) 385-387
13. Kammermeier P.J., Xiao B., Tu J.C., Worley P.F., and Ikeda S.R. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J. Neurosci. 20 (2000) 7238-7245
14. Kato A., Ozawa F., Saitoh Y., Hirai K., and Inokuchi K. Vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett. 412 (1997) 183-189
15. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers Jr. M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51 (1994) 199-214
16. Krystal J.H., Perry Jr. E.B., Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., Cooper T.B., Macdougall L., Abi-Saab W., and D'Souza D.C. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch. Gen. Psychiatry 62 (2005) 985-994
17. Lipska B.K., Peters T., Hyde T.M., Halim N., Horowitz C., Mitkus S., Weickert C.S., Matsumoto M., Sawa A., Straub R.E., Vakkalanka R., Herman M.M., Weinberger D.R., and Kleinman J.E. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15 (2006) 1245-1258
18. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
19. Miyabe T., Miletic G., and Miletic V. Loose ligation of the sciatic nerve in rats elicits transient up-regulation of Homer1a gene expression in the spinal dorsal horn. Neurosci. Lett. 398 (2006) 296-299
20. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17 (1997) 2921-2927
21. Morioka R., Kato A., Fueta Y., and Sugiyama H. Expression of vesl-1S/homer-1a, a gene associated with long-term potentiation, in the brain of the epileptic EI mouse. Neurosci. Lett. 313 (2001) 99-101
22. Murray K.D., Isackson P.J., and Jones E.G. N-methyl-d-aspartate receptor dependent transcriptional regulation of two calcium/calmodulin-dependent protein kinase type II isoforms in rodent cerebral cortex. Neuroscience 122 (2003) 407-420
23. Oh J.D., Vaughan C.L., and Chase T.N. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res. 821 (1999) 433-442
24. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatry Res. 33 (1999) 523-533
25. Pan Y., Siregar E., and Carr K.D. Striatal cell signaling in chronically food-restricted rats under basal conditions and in response to brief handling. Neurosci. Lett. 393 (2006) 243-248
26. Paxinos G., and Watson C. The Rat Brain Stereotaxic Coordinates (1997), Academic Press
27. Razoux F., Garcia R., and Lena I. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology (2006)
28. Sakagami Y., Yamamoto K., Sugiura S., Inokuchi K., Hayashi T., and Kato N. Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock. Eur. J. Neurosci. 21 (2005) 3229-3239
29. Schiffer W.K., Logan J., and Dewey S.L. Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine. Neuropsychopharmacology 28 (2003) 2192-2198
30. Shen K., and Meyer T. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 284 (1999) 162-166
31. Szumlinski K.K., Abernathy K.E., Oleson E.B., Klugmann M., Lominac K.D., He D.Y., Ron D., During M., and Kalivas P.W. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology 31 (2006) 768-777
32. Szumlinski K.K., Lominac K.D., Kleschen M.J., Oleson E.B., Dehoff M.H., Schwarz M.K., Seeburg P.H., Worley P.F., and Kalivas P.W. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav. 4 (2005) 273-288
33. Tsukada H., Harada N., Nishiyama S., Ohba H., Sato K., Fukumoto D., and Kakiuchi T. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Synapse 37 (2000) 95-103
34. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J.C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., Greengard P., Herve D., and Girault J.A. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 491-496
35. Wadenberg M.L., Soliman A., VanderSpek S.C., and Kapur S. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25 (2001) 633-641
36. Westerink B.H., Kawahara Y., De Boer P., Geels C., De Vries J.B., Wikstrom H.V., Van Kalkeren A., Van Vliet B., Kruse C.G., and Long S.K. Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur. J. Pharmacol. 412 (2001) 127-138
37. Yano M., Beverley J.A., and Steiner H. Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140 (2006) 699-709
38. Yoshimura Y., Shinkawa T., Taoka M., Kobayashi K., Isobe T., and Yamauchi T. Identification of protein substrates of Ca(2+)/calmodulin-dependent protein kinase II in the postsynaptic density by protein sequencing and mass spectrometry. Biochem. Biophys. Res. Commun. 290 (2002) 948-954